Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

U.N. Reclassifies Cannabis as a Less Dangerous Drug
U.N. Reclassifies Cannabis as a Less Dangerous Drug
A United Nations commission voted on Wednesday to remove cannabis for medicinal purposes from a category of the world’s most dangerous drugs, a highly anticipated and long-delayed decision that coul...
AZ sells rights to statin med Crestor to Grünenthal
AZ sells rights to statin med Crestor to Grünenthal
AstraZeneca (AZ) has announced that it will sell the rights to statin medication Crestor to Grünenthal in over 30 European countries.
In world first, UK approves Pfizer-BioNTech COVID-19 vaccine
In world first, UK approves Pfizer-BioNTech COVID-19 vaccine
LONDON (Reuters) - Britain approved Pfizer’s COVID-19 vaccine on Wednesday, jumping ahead of the rest of the world in the race to begin the most crucial mass inoculation programme in history...
INTERPOL warns of organized crime threat to COVID-19 vaccines
INTERPOL warns of organized crime threat to COVID-19 vaccines
LYON, France – INTERPOL has issued a global alert to law enforcement across its 194 member countries warning them to prepare for organized crime networks targeting COVID-19 vaccines, both physically...
Sensor can detect scarred or fatty liver tissue
Sensor can detect scarred or fatty liver tissue
About 25 percent of the U.
Novavax expects delayed U.S. COVID-19 vaccine trial to start in coming weeks
Novavax expects delayed U.S. COVID-19 vaccine trial to start in coming weeks
(Reuters) - Novavax Inc on Monday pushed back the start of a U.
Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA
Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA
NEW YORK and MAINZ, GERMANY, December 1, 2020 — Pfizer Inc.
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19
THOUSAND OAKS, Calif.
FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate
FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate
The U.
Moderna to file for FDA emergency use authorization for COVID-19 vaccine
Moderna to file for FDA emergency use authorization for COVID-19 vaccine
Moderna announced that it plans to file with the FDA Monday for an emergency use authorization for its coronavirus vaccine, which the company said has an efficacy rate of 94.
Teladoc eyes several new phases of growth for telemedicine
Teladoc eyes several new phases of growth for telemedicine
Fresh off a big acquisition and riding a wave of customer growth, Teladoc Health is ready to do more for patients.
Dr. Reddy’s to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Dr. Reddy’s to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Hyderabad, India.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand